Serum Alkaline Phosphatase and outcome in ARDS Patients A retrospective observational study

Serum Alkaline Phosphatase and outcome in ARDS Patients A retrospective observational study - Serum Alkaline Phosphatase and outcome in ARDS Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000051190

Enrollment

Registered

2024-01-01

Start date

2023-05-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory distress syndrome and serum alkaline phosphatase

Interventions

Clinical data for assessment of progress of patients: Oxygenation, ventilatory and lung mechanics, and radiological data: ABGs (Pao2&amp

PaCo2) PaO2/FiO2 ratio PEEP and peak and plateau pressures. Lung ultrasound

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who will be included conformed to the diagnostic criteria of acute respiratory distress syndrome

Exclusion criteria

Exclusion criteria: Exclusion of patients with liver and kidney diseases, cancer patients and autoimmune illness and patients who develop marked hemodynamic instability or need vasoactive drugs.

Design outcomes

Primary

Measure	Time frame
Primary aim of the study will be to evaluate the relevance between serum ALP and ARDS severity	—

Secondary

Measure	Time frame
Correlate between clinical improvement or deterioration of clinical parameters and serum ALP level	—

Countries

Africa

Contacts

Public ContactGhada Hassan

Menofia University Anesthesia, Intinsve care and pain management department

ghada.ibrahim@med.menofia.edu.eg00201001592001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026